To further evaluate the function of LOXL2 on the tumorigenesis and progression of glioma, we assessed the role of LOXL2 overexpression in glioma cells and confirmed the results obtained via western blotting and qPCR (Supplementary Figures 2B, D). This evidence concerns the gene LOXL2 and central nervous system cancer.